
Kyowa Hakko USA is thrilled to announce that our groundbreaking product, IMMUSE™ postbiotic for immune health, has been honored as the inaugural recipient of the the Ingredient of the Year: Microbiome Modulation category in the esteemed annual awards by NutraIngredients-USA. Read more »
Launch Hydrate™ recently announced their game-changing sports drinks featuring Cognizin® Citicoline. With a unique blend of electrolytes and essential vitamins and minerals, athletes will be able to hydrate quickly, focus better and recover faster. Read more »
Nectr Energy recently launched their Nectr Nootropics mouth pouches featuring Cognizin® Citicoline. Focused on the energy pouch sector, the brand decided to introduce this innovative delivery system coupled with a key ingredient that was backed by research. Read more »
Kyowa Hakko’s IMMUSE™, a research-backed postbiotic, provides immune support for travelers in this new innovative formula, “Well Traveled Immune Activator." Read more »
Kyowa Hakko’s Cognizin®, a research-backed nootropic, provides brain health support in this new First-of-its-Kind formula, delivered in a simple single-serve sachet Read more »
Kyowa Hakko USA is excited to announce the launch of CENTR Enhanced sparkling water, a functional beverage with a blend of nootropic and adaptogenic ingredients that includes its Cognizin® citicoline. Read more »
After a resoundingly successful limited-time offering, Glaxon™ has now added Kyowa Hakko’s IMMUSE™ to all SuperGreens Immune formulas. Glaxon™, producer of sports nutrition dietary supplements, launched this summer a SuperGreens Enhanced Immune Edition that, in addition to the power of Glaxon™'s trademarked Supershrooms® Organic Mushroom Blend, included IMMUSE™, a postbiotic that provides immune support at a cellular level - both of which support the immune systems of its customers. Read more »
The Tap Challenge App is finally here for professional button mashers or anyone who wants to challenge themselves each day! Read more »
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety evaluation by the Chinese Ministry of Agriculture and Rural Affairs (MARA), while other manufacturing strains used for producing 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) are currently under review. Read more »
One of Kyowa Hakko’s own is honored for the enhancement of citicoline, which helps healthy elderly adults improve memory function Read more »